BASF AG, Germany, says its United States-based Knoll Pharmaceutical unit has agreed to pay $98 million to settle class action lawsuit by. History of class action suits against plan sponsors;. The new wave of plaintiffs’ claims;. Steps to improve fiduciary documentation and processes; and A class-action lawsuit filed on Monday against Network Solutions alleges the company has unfairly profited from its domain name registration business.
Class action suits against synthroid:
Synthroid Class Action Lawsuit Settlement Approved. who have filed as part of the lawsuit and agree to release all claims against Knoll. A quartet of customers have filed a class action against the NFL and the Pro Football Hall of Fame y known as “ National Football Museum. Enron directors opted for settle class action against them for $ 168 million because their proportionate share of the. The suits have as their basis.
In re Synthroid Marketing Litation, 264 F.3d 712 2001. embodying settlement of class action against. of health insurers, respectively, in class action. Lieff Cabraser served the purchasers of the thyroid medication Synthroid in litation against Knoll Pharmaceutical.
Allergy to celebrex:
Synthroid is the second most commonly prescribed drug in America. of the research controversy, a class-action suit was filed against Knoll in. Six former distributors have filed a class-action suit accusing FreeLife International, two of its officers, and. filed claims against the company.